Chapter 4 Molecular Mechanisms of Adaptation to Folate Deficiency

Vitamins and Hormones

Volumn 79, Issue , 2008, Pages 99-143

  Ifergan, Ilan ^a   Assaraf, Yehuda G ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; FOLIC ACID;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; CONGENITAL HEART MALFORMATION; DRUG RESISTANCE; FOLIC ACID DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERHOMOCYSTEINEMIA; METABOLISM; MOUSE; NEOPLASM; NEURAL TUBE DEFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; ATHEROSCLEROSIS; CARRIER PROTEINS; DRUG RESISTANCE, NEOPLASM; FOLIC ACID; FOLIC ACID DEFICIENCY; GENE EXPRESSION REGULATION; HEART DEFECTS, CONGENITAL; HUMANS; HYPERHOMOCYSTEINEMIA; MICE; NEOPLASMS; NEURAL TUBE DEFECTS;

EID: 52049094603     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)00404-4     Document Type: Review

References (197)

1. Abdel Nour A.M., Ringot D., Gueant J.L., and Chango A. Folate receptor and human reduced folate carrier expression in HepG2 cell line exposed to fumonisin B1 and folate deficiency. Carcinogenesis 28 (2007) 2291-2297
2. Abdul-Ghani R., Serra V., Gyorffy B., Jurchott K., Solf A., Dietel M., and Schafer R. The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene 25 12 (2006) 1743-1752
3. Adams J.F., Tankel H.I., and MacEwan F. Estimation of the total body vitamin B12 in the live subject. Clin. Sci. 39 1 (1970) 107-113
4. Allegra C.J., Chabner B.A., Drake J.C., Lutz R., Rodbard D., and Jolivet J. Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates. J. Biol. Chem. 260 17 (1985) 9720-9726
5. Allegra C.J., Hoang K., Yeh G.C., Drake J.C., and Baram J. Evidence for direct inhibition of de novo purine synthesis in human MCF-7 breast cells as a principal mode of metabolic inhibition by methotrexate. J. Biol. Chem. 262 28 (1987) 13520-13526
6. Alperin J.B., and Haggard M.E. Cerebrospinal fluid folate (CFA) and the blood-brain barrier. Clin. Res. 40 (1970) 18-23
7. Antony A.C. The biological chemistry of folate receptors. Blood 79 11 (1992) 2807-2820
8. Antony A.C. Folate receptors. Annu. Rev. Nutr. 16 (1996) 501-521
9. Arnesen E., Refsum H., Bonaa K.H., Ueland P.M., Forde O.H., and Nordrehaug J.E. Serum total homocysteine and coronary heart disease. Int. J. Epidemiol. 24 4 (1995) 704-709
10. Assantachai P., and Lekhakula S. Epidemiological survey of vitamin deficiencies in older Thai adults: implications for national policy planning. Public Health Nutr. 10 1 (2007) 65-70
11. Assaraf Y.G. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. Drug Resist. Updat. 9 4-5 (2006) 227-246
12. Assaraf Y.G. Molecular basis of antifolate resistance. Cancer Metastasis. Rev. 26 1 (2007) 153-181
13. Assaraf Y.G., Babani S., and Goldman I.D. Increased activity of a novel low pH folate transporter associated with lipophilic antifolate resistance in chinese hamster ovary cells. J. Biol. Chem. 273 14 (1998) 8106-8111
14. Assaraf Y.G., and Goldman I.D. Loss of folic acid exporter function with markedly augmented folate accumulation in lipophilic antifolate-resistant mammalian cells. J. Biol. Chem. 272 28 (1997) 17460-17466
15. Assaraf Y.G., Ifergan I., Kadry W.N., and Pinter R.Y. Computer modelling of antifolate inhibition of folate metabolism using hybrid functional petri nets. J. Theor. Biol. 240 4 (2006) 637-647
16. Assaraf Y.G., Rothem L., Hooijberg J.H., Stark M., Ifergan I., Kathmann I., Dijkmans B.A., Peters G.J., and Jansen G. Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells. J. Biol. Chem. 278 9 (2003) 6680-6686
17. Assaraf Y.G., and Slotky J.I. Characterization of a lipophilic antifolate resistance provoked by treatment of mammalian cells with the antiparasitic agent pyrimethamine. J. Biol. Chem. 268 6 (1993) 4556-4566
18. Backus H.H., Pinedo H.M., Wouters D., Padron J.M., Molders N., van Der Wilt C.L., van Groeningen C.J., Jansen G., and Peters G.J. Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates. Int. J. Cancer 87 6 (2000) 771-778
19. Bailey-Dell K.J., Hassel B., Doyle L.A., and Ross D.D. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim. Biophys. Acta 1520 3 (2001) 234-241
20. Bailey L.B., Wagner P.A., Christakis G.J., Davis C.G., Appledorf H., Araujo P.E., Dorsey E., and Dinning J.S. Folacin and iron status and hematological findings in black and Spanish-American adolescents from urban low-income households. Am. J. Clin. Nutr. 35 5 (1982) 1023-1032
21. Bertino J.R. Karnofsky memorial lecture. Ode to methotrexate. J. Clin. Oncol. 11 1 (1993) 5-14
22. Birn H. The kidney in vitamin B12 and folate homeostasis: characterization of receptors for tubular uptake of vitamins and carrier proteins. Am. J. Physiol. Renal. Physiol. 291 1 (2006) F22-F36
23. Blom H.J., Shaw G.M., den Heijer M., and Finnell R.H. Neural tube defects and folate: Case far from closed. Nat. Rev. Neurosci. 7 9 (2006) 724-731
24. Boll M., Foltz M., Rubio-Aliaga I., Kottra G., and Daniel H. Functional characterization of two novel mammalian electrogenic proton-dependent amino acid cotransporters. J. Biol. Chem. 277 25 (2002) 22966-22973
25. Borgnia M.J., Eytan G.D., and Assaraf Y.G. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J. Biol. Chem. 271 6 (1996) 3163-3171
26. Borst P., Balzarini J., Ono N., Reid G., de Vries H., Wielinga P., Wijnholds J., and Zelcer N. The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy. Antiviral Res. 62 1 (2004) 1-7
27. Borst P., and Elferink R.O. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71 (2002) 537-592
28. Borst P., Evers R., Kool M., and Wijnholds J. A family of drug transporters: The multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92 16 (2000) 1295-1302
29. Boyer M.J., and Tannock I.F. Regulation of intracellular pH in tumor cell lines: Influence of microenvironmental conditions. Cancer Res. 52 16 (1992) 4441-4447
30. Breedveld P., Pluim D., Cipriani G., Dahlhaus F., van Eijndhoven M.A., de Wolf C.J., Kuil A., Beijnen J.H., Scheffer G.L., Jansen G., Borst P., and Schellens J.H. The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models. Mol. Pharmacol. 71 1 (2007) 240-249
31. Brigle K.E., Spinella M.J., Westin E.H., and Goldman I.D. Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells. Biochem. Pharmacol. 47 2 (1994) 337-345
32. Carmel R., Green R., Rosenblatt D.S., and Watkins D. Update on cobalamin, folate, and homocysteine. Hematology Am. Soc. Hematol. Educ. Program (2003) 62-81
33. Chandler C.J., Wang T.T., and Halsted C.H. Pteroylpolyglutamate hydrolase from human jejunal brush borders. Purification and characterization. J. Biol. Chem. 261 2 (1986) 928-933
34. Chen Z.S., Lee K., Walther S., Raftogianis R.B., Kuwano M., Zeng H., and Kruh G.D. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res. 62 11 (2002) 3144-3150
35. Chen Z.S., Robey R.W., Belinsky M.G., Shchaveleva I., Ren X.Q., Sugimoto Y., Ross D.D., Bates S.E., and Kruh G.D. Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: Effects of acquired mutations at R482 on methotrexate transport. Cancer Res. 63 14 (2003) 4048-4054
36. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., and Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258 5088 (1992) 1650-1654
37. Cools J., Maertens C., and Marynen P. Resistance to tyrosine kinase inhibitors: Calling on extra forces. Drug Resist. Updat. 8 3 (2005) 119-129
38. da Costa M., and Rothenberg S.P. Purification and characterization of folate binding proteins from rat placenta. Biochim. Biophys. Acta 1292 1 (1996) 23-30
39. da Costa M., Rothenberg S.P., Sadasivan E., Regec A., and Qian L. Folate deficiency reduces the GPI-anchored folate-binding protein in rat renal tubules. Am. J. Physiol. Cell Physiol. 278 4 (2000) C812-C821
40. da Costa M., Sequeira J.M., Rothenberg S.P., and Weedon J. Antibodies to folate receptors impair embryogenesis and fetal development in the rat. Birth Defects Res. A Clin. Mol. Teratol. 67 10 (2003) 837-847
41. Dean M. The human ATP-binding cassette (ABC) transporter superfamily (2002), NCBI Monographs. National Library of Medicine, Bethesda, MD, USA
42. Dean M., and Allikmets R. Complete characterization of the human ABC gene family. J. Bioenerg. Biomembr. 33 6 (2001) 475-479
43. Deeley R.G., Westlake C., and Cole S.P. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol. Rev. 86 3 (2006) 849-899
44. Dembo M S.F. Membrane transport of folate compounds in mammalian cells (1984)
45. Dembo M S.F. Membrane transport of folate compounds in mammalian cells. Folate Antagonists as Therapeutic Agents 1 (1984), Academic, New York
46. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., and Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 95 26 (1998) 15665-15670
47. Drori S., Sprecher H., Shemer G., Jansen G., Goldman I.D., and Assaraf Y.G. Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells. Eur. J. Biochem. 267 3 (2000) 690-702
48. Durand P., Prost M., Loreau N., Lussier-Cacan S., and Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab. Invest. 81 5 (2001) 645-672
49. Ee P.L., Kamalakaran S., Tonetti D., He X., Ross D.D., and Beck W.T. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 64 4 (2004) 1247-1251
50. Elnakat H., and Ratnam M. Distribution, functionality and gene regulation of folate receptor isoforms: Implications in targeted therapy. Adv. Drug. Deliv. Rev. 56 8 (2004) 1067-1084
51. Elnakat H., and Ratnam M. Role of folate receptor genes in reproduction and related cancers. Front Biosci. 11 (2006) 506-519
52. Elwood P.C. Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. J. Biol. Chem. 264 25 (1989) 14893-14901
53. Fei Y.J., Kanai Y., Nussberger S., Ganapathy V., Leibach F.H., Romero M.F., Singh S.K., Boron W.F., and Hediger M.A. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368 6471 (1994) 563-566
54. Ferguson P.L., and Flintoff W.F. Topological and functional analysis of the human reduced folate carrier by hemagglutinin epitope insertion. J. Biol. Chem. 274 23 (1999) 16269-16278
55. Fromm M.F. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv. Drug. Deliv. Rev. 54 10 (2002) 1295-12310
56. Gatenby R.A., and Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 4 11 (2004) 891-899
57. Gates S.B., Mendelsohn L.G., Shackelford K.A., Habeck L.L., Kursar J.D., Gossett L.S., Worzalla J.F., Shih C., and Grindey G.B. Characterization of folate receptor from normal and neoplastic murine tissue: Influence of dietary folate on folate receptor expression. Clin. Cancer Res. 2 7 (1996) 1135-1141
58. Geller J., Kronn D., Jayabose S., and Sandoval C. Hereditary folate malabsorption: Family report and review of the literature. Medicine (Baltimore) 81 1 (2002) 51-68
59. Goldman I.D. The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann. NY Acad. Sci. 186 (1971) 400-422
60. Goldman I.D., and Matherly L.H. The cellular pharmacology of methotrexate Int. Encyl. Pharmacol. Ther. 118 (1986), Pergamon, Oxford/NewYork 283-302
61. Gong M., Cowan K.H., Gudas J., and Moscow J.A. Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1). Gene 233 1-2 (1999) 21-31
62. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. Cancer 2 1 (2002) 48-58
63. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M., Palma-Reis R.J., Boers G.H.J., Sheahan R.G., Israelsson B., Uiterwaal C.S., Meleady R., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277 (1997) 1775-1781
64. Graham I.M., and O'Callaghan P. The role of folic acid in the prevention of cardiovascular disease. Curr. Opin. Lipidol. 11 6 (2000) 577-587
65. Group V.S.R. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Lancet Jul 20 338 8760 (1991) 131-137
66. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., and Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388 6641 (1997) 482-488
67. Hafkemeyer P., Dey S., Ambudkar S.V., Hrycyna C.A., Pastan I., and Gottesman M.M. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein. Biochemistry 37 46 (1998) 16400-16409
68. Hayashi I., Sohn K.J., Stempak J.M., Croxford R., and Kim Y.I. Folate deficiency induces cell-specific changes in the steady-state transcript levels of genes involved in folate metabolism and 1-carbon transfer reactions in human colonic epithelial cells. J. Nutr. 137 3 (2007) 607-613
69. Holm J., Hansen S.I., Hoier-Madsen M., and Bostad L. High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein. Biochem. J. 280 Pt 1 (1991) 267-271
70. Hooijberg J.H., Broxterman H.J., Kool M., Assaraf Y.G., Peters G.J., Noordhuis P., Scheper R.J., Borst P., Pinedo H.M., and Jansen G. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res. 59 11 (1999) 2532-2535
71. Hooijberg J.H., Jansen G., Assaraf Y.G., Kathmann I., Pieters R., Laan A.C., Veerman A.J., Kaspers G.J., and Peters G.J. Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1). Biochem. Pharmacol. 67 8 (2004) 1541-1548
72. Hooijberg J.H., Peters G.J., Assaraf Y.G., Kathmann I., Priest D.G., Bunni M.A., Veerman A.J., Scheffer G.L., Kaspers G.J., and Jansen G. The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis. Biochem. Pharmacol. 65 5 (2003) 765-771
73. Hopper E., Belinsky M.G., Zeng H., Tosolini A., Testa J.R., and Kruh G.D. Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. Cancer Lett. 162 2 (2001) 181-191
74. Horns Jr. R.C., Dower W.J., and Schimke R.T. Gene amplification in a leukemic patient treated with methotrexate. J. Clin. Oncol. 2 1 (1984) 2-7
75. Ifergan I., Jansen G., and Assaraf Y.G. Cytoplasmic confinement of breast cancer resistance protein (BCRP/ABCG2) as a novel mechanism of adaptation to short-term folate deprivation. Mol. Pharmacol. 67 4 (2005) 1349-1359
76. Ifergan I., Shafran A., Jansen G., Hooijberg J.H., Scheffer G.L., and Assaraf Y.G. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis. J. Biol. Chem. 279 24 (2004) 25527-25534
77. Ishikawa T. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem. Sci. 17 11 (1992) 463-468
78. Jackson R.C., and Harrap K.R. Studies with a mathematical model of folate metabolism. Arch. Biochem. Biophys. 158 2 (1973) 827-841
79. James S.J., Basnakian A.G., and Miller B.J. In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Res. 54 19 (1994) 5075-5080
80. Jansen G., Westerhof G.R., Jarmuszewski M.J., Kathmann I., Rijksen G., and Schornagel J.H. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J. Biol. Chem. 265 30 (1990) 18272-18277
81. Joelson D.W., Fiebig E.W., and Wu A.H. Diminished need for folate measurements among indigent populations in the post folic acid supplementation era. Arch. Pathol. Lab. Med. 131 3 (2007) 477-480
82. Jonker J.W., Buitelaar M., Wagenaar E., Van Der Valk M.A., Scheffer G.L., Scheper R.J., Plosch T., Kuipers F., Elferink R.P., Rosing H., Beijnen J.H., and Schinkel A.H. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA 99 24 (2002) 15649-15654
83. Jonker J.W., Merino G., Musters S., van Herwaarden A.E., Bolscher E., Wagenaar E., Mesman E., Dale T.C., and Schinkel A.H. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat. Med. 11 2 (2005) 127-129
84. Jukes T.H. Searching for magic bullets: early approaches to chemotherapy-antifolates, methotrexate-the Bruce F. Cain memorial award lecture. Cancer Res. 47 21 (1987) 5528-5536
85. Kane M.A., Elwood P.C., Portillo R.M., Antony A.C., Najfeld V., Finley A., Waxman S., and Kolhouse J.F. Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human cells. J. Clin. Invest. 81 5 (1988) 1398-1406
86. Keppler D., Leier I., and Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol. Chem. 378 8 (1997) 787-791
87. Kim Y.I. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer?. Cancer Epidemiol. Biomarkers Prev. 13 4 (2004) 511-519
88. Kim Y.I. Nutritional epigenetics: Impact of folate deficiency on DNA methylation and colon cancer susceptibility. J. Nutr. 135 11 (2005) 2703-2709
89. Konig P., Giraldo R., Chapman L., and Rhodes D. The crystal structure of the DNA-binding domain of yeast RAP1 in complex with telomeric DNA. Cell 85 1 (1996) 125-136
90. Krishnamurthy P., and Schuetz J.D. Role of ABCG2/BCRP in biology and medicine. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 381-410
91. Kruh G.D., and Belinsky M.G. The MRP family of drug efflux pumps. Oncogene 22 47 (2003) 7537-7552
92. Kusuhara H., Han Y.H., Shimoda M., Kokue E., Suzuki H., and Sugiyama Y. Reduced folate derivatives are endogenous substrates for cMOAT in rats. Am J. Physiol. 275 4 Pt 1 (1998) G789-G796
93. Lacey S.W., Sanders J.M., Rothberg K.G., Anderson R.G., and Kamen B.A. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J. Clin. Invest. 84 2 (1989) 715-720
94. Lamers Y., Prinz-Langenohl R., Bramswig S., and Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am. J. Clin. Nutr. 84 1 (2006) 156-161
95. Laurence K.M., James N., Miller M.H., Tennant G.B., and Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br. Med. J. (Clin. Res. Ed.) 282 6275 (1981) 1509-1511
96. Lee H.C., Shoda R., Krall J.A., Foster J.D., Selhub J., and Rosenberry T.L. Folate binding protein from kidney brush border membranes contains components characteristic of a glycoinositol phospholipid anchor. Biochemistry 31 12 (1992) 3236-3243
97. Liani E., Rothem L., Bunni M.A., Smith C.A., Jansen G., and Assaraf Y.G. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines. Int. J. Cancer 103 5 (2003) 587-599
98. Lin B.F., Huang R.F., and Shane B. Regulation of folate and one-carbon metabolism in mammalian cells. III. Role of mitochondrial folylpoly-gamma-glutamate synthetase. J. Biol. Chem. 268 29 (1993) 21674-21679
99. Liu X.Y., and Matherly L.H. Analysis of membrane topology of the human reduced folate carrier protein by hemagglutinin epitope insertion and scanning glycosylation insertion mutagenesis. Biochim. Biophys. Acta 1564 2 (2002) 333-342
100. Loo T.W., and Clarke D.M. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein. Biochemistry 33 47 (1994) 14049-14057
101. Lubhy A.L., Eagle F.J., Roth E., and Cooperman J.M. Relapsing megaloblastic anemia in an infant due to a specific defect in gastrointestinal absorption of folic acid. Am. J. Dis. Child 102 (1961) 482-483
102. Ma L., Krishnamachary N., and Center M.S. Phosphorylation of the multidrug resistance associated protein gene encoded protein P190. Biochemistry 34 10 (1995) 3338-3343
103. Maliepaard M., van Gastelen M.A., Tohgo A., Hausheer F.H., van Waardenburg R.C., de Jong L.A., Pluim D., Beijnen J.H., and Schellens J.H. Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918. Clin. Cancer Res. 7 4 (2001) 935-941
104. Mason J.B., and Rosenberg I.H. Intestinal absorption of folate. In: Johnson L.R. (Ed). Physiology of the Gastrointestinal Tract (1994), Raven Press, New York 1979-1995
105. Matherly L.H., and Goldman D.I. Membrane transport of folates. Vitam. Horm. 66 (2003) 403-456
106. McEwan G.T., Lucas M.L., Denvir M., Raj M., McColl K.E., Russell R.I., and Mathan V.I. A combined TDDA-PVC pH and reference electrode for use in the upper small intestine. J. Med. Eng. Technol. 14 1 (1990) 16-20
107. McGuire J.J., Russell C.A., and Balinska M. Human cytosolic and mitochondrial folylpolyglutamate synthetase are electrophoretically distinct. Expression in antifolate-sensitive and -resistant human cell lines. J. Biol. Chem. 275 17 (2000) 13012-13016
108. McHugh M., and Cheng Y.C. Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J. Biol. Chem. 254 22 (1979) 11312-11318
109. Melnyk S., Pogribna M., Miller B.J., Basnakian A.G., Pogribny I.P., and James S.J. Uracil misincorporation, DNA strand breaks, and gene amplification are associated with tumorigenic cell transformation in folate deficient/repleted Chinese hamster ovary cells. Cancer Lett. 146 1 (1999) 35-44
110. Miyake K., Mickley L., Litman T., Zhan Z., Robey R., Cristensen B., Brangi M., Greenberger L., Dean M., Fojo T., and Bates S.E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes. Cancer Res. 59 1 (1999) 8-13
111. Mogi M., Yang J., Lambert J.F., Colvin G.A., Shiojima I., Skurk C., Summer R., Fine A., Quesenberry P.J., and Walsh K. Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J. Biol. Chem. 278 40 (2003) 39068-39075
112. Morgillo F., and Lee H.Y. Resistance to epidermal growth factor receptor-targeted therapy. Drug Resist. Updat. 8 5 (2005) 298-310
113. Nguyen T.T., Dyer D.L., Dunning D.D., Rubin S.A., Grant K.E., and Said H.M. Human intestinal folate transport: Cloning, expression, and distribution of complementary RNA. Gastroenterology 112 3 (1997) 783-791
114. Nozawa T., Imai K., Nezu J., Tsuji A., and Tamai I. Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J. Pharmacol Exp. Ther. 308 2 (2004) 438-445
115. Ozaki Y., King R.W., and Carey P.R. Methotrexate and folate binding to dihydrofolate reductase. Separate characterization of the pteridine and p-aminobenzoyl binding sites by resonance Raman spectroscopy. Biochemistry 20 11 (1981) 3219-3225
116. Ozvegy C., Litman T., Szakacs G., Nagy Z., Bates S., Varadi A., and Sarkadi B. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem. Biophys. Res. Commun. 285 1 (2001) 111-117
117. Pathak P., Kapil U., Kapoor S.K., Saxena R., Kumar A., Gupta N., Dwivedi S.N., Singh R., and Singh P. Prevalence of multiple micronutrient deficiencies amongst pregnant women in a rural area of Haryana. Indian J. Pediatr. 71 11 (2004) 1007-1014
118. Paulusma C.C., Bosma P.J., Zaman G.J., Bakker C.T., Otter M., Scheffer G.L., Scheper R.J., Borst P., and Oude Elferink R.P. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271 5252 (1996) 1126-1128
119. Piedrahita J.A., Oetama B., Bennett G.D., van Waes J., Kamen B.A., Richardson J., Lacey S.W., Anderson R.G., and Finnell R.H. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat. Genet. 23 2 (1999) 228-232
120. Polgar O., Ozvegy-Laczka C., Robey R.W., Morisaki K., Okada M., Tamaki A., Koblos G., Elkind N.B., Ward Y., Dean M., Sarkadi B., and Bates S.E. Mutational studies of G553 in TM5 of ABCG2: A residue potentially involved in dimerization. Biochemistry 45 16 (2006) 5251-5260
121. Polgar O., Robey R.W., Morisaki K., Dean M., Michejda C., Sauna Z.E., Ambudkar S.V., Tarasova N., and Bates S.E. Mutational analysis of ABCG2: role of the GXXXG motif. Biochemistry 43 29 (2004) 9448-9456
122. Poncz M., and Cohen A. Long-term treatment of congenital folate malabsorption. J. Pediatr. 129 6 (1996) 948
123. Qiu A., Jansen M., Sakaris A., Min S.H., Chattopadhyay S., Tsai E., Sandoval C., Zhao R., Akabas M.H., and Goldman I.D. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127 5 (2006) 917-928
124. Qureshi A.A., Rosenblatt D.S., and Cooper B.A. Inherited disorders of cobalamin metabolism. Crit. Rev. Oncol. Hematol. 17 2 (1994) 133-151
125. Ramaekers V.T., and Blau N. Cerebral folate deficiency. Dev. Med. Child. Neurol. 46 12 (2004) 843-851
126. Ramaekers V.T., Hausler M., Opladen T., Heimann G., and Blau N. Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: A novel neurometabolic condition responding to folinic acid substitution. Neuropediatrics 33 6 (2002) 301-308
127. Ramaekers V.T., Rothenberg S.P., Sequeira J.M., Opladen T., Blau N., Quadros E.V., and Selhub J. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N. Engl. J. Med. 352 19 (2005) 1985-1991
128. Ramakrishnan S., Sulochana K.N., Lakshmi S., Selvi R., and Angayarkanni N. Biochemistry of homocysteine in health and diseases. Indian J. Biochem. Biophys. 43 5 (2006) 275-283
129. Rasouli M.L., Nasir K., Blumenthal R.S., Park R., Aziz D.C., and Budoff M.J. Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis 181 1 (2005) 159-165
130. Ratnam M., and Freisheim J.H. Proteins involved in the transport of folates and antifolates by normal and neoplastic cells. In: Picciano M.F., Stokstad E.L.R., and Gregory J.F. (Eds). Folic Acid Metabolism in Health and Disease (1992), Wiley-Liss, Inc, New York 91-120
131. Ratnam M., Marquardt H., Duhring J.L., and Freisheim J.H. Homologous membrane folate binding proteins in human placenta: Cloning and sequence of a cDNA. Biochemistry 28 20 (1989) 8249-8254
132. Richards R.G., Brown O.E., Gillison M.L., and Sedwick W.D. Drug concentration-dependent DNA lesions are induced by the lipid-soluble antifolate, piritrexim (BW301U). Mol. Pharmacol. 30 6 (1986) 651-658
133. Rothem L., Ifergan I., Kaufman Y., Priest D.G., Jansen G., and Assaraf Y.G. Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines. Biochem. J. 367 Pt 3 (2002) 741-750
134. Rothenberg S.P., da Costa M.P., Sequeira J.M., Cracco J., Roberts J.L., Weedon J., and Quadros E.V. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N. Engl. J. Med. 350 2 (2004) 134-142
135. Rubin R.C., Henderson E.S., Owens E.S., and Rall D.P. Uptake of methotrexate-3H by rabbit kidney slices. Cancer Res. 27 3 (1967) 553-557
136. Sadasivan E., and Rothenberg S.P. The complete amino acid sequence of a human folate binding protein from KB cells determined from the cDNA. J. Biol. Chem. 264 10 (1989) 5806-5811
137. Saier Jr. M.H., Beatty J.T., Goffeau A., Harley K.T., Heijne W.H., Huang S.C., Jack D.L., Jahn P.S., Lew K., Liu J., Pao S.S., Paulsen I.T., et al. The major facilitator superfamily. J. Mol. Microbiol. Biotechnol. 1 2 (1999) 257-279
138. Sarkadi B., Muller M., Homolya L., Hollo Z., Seprodi J., Germann U.A., Gottesman M.M., Price E.M., and Boucher R.C. Interaction of bioactive hydrophobic peptides with the human multidrug transporter. Faseb. J. 8 10 (1994) 766-770
139. Sauls D.L., Arnold E.K., Bell C.W., Allen J.C., and Hoffman M. Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia. Thromb. Res. 120 1 (2007) 117-126
140. Sauls D.L., Boyd L.C., Allen J.C., and Hoffman M. Differences in the metabolic response to exogenous homocysteine in juvenile and adult rabbits. J. Nutr. Biochem. 15 2 (2004) 96-102
141. Sauls D.L., Lockhart E., Warren M.E., Lenkowski A., Wilhelm S.E., and Hoffman M. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: A potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry 45 8 (2006) 2480-2487
142. Schimke R.T. Gene amplification in cultured animal cells. Cell 37 3 (1984) 705-713
143. Schinkel A.H., Mayer U., Wagenaar E., Mol C.A., van Deemter L., Smit J.J., van der Valk M.A., Voordouw A.C., Spits H., van Tellingen O., Zijlmans J.M., Fibbe W.E., et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94 8 (1997) 4028-4033
144. Schmitt L., and Tampe R. Affinity, specificity, diversity: A challenge for the ABC transporter TAP in cellular immunity. Chembiochem. 1 1 (2000) 16-35
145. Scott J.M. Folate and vitamin B12. Proc. Nutr. Soc. 58 2 (1999) 441-448
146. Seither R.L., Trent D.F., Mikulecky D.C., Rape T.J., and Goldman I.D. Folate-pool interconversions and inhibition of biosynthetic processes after exposure of L1210 leukemia cells to antifolates. Experimental and network thermodynamic analyses of the role of dihydrofolate polyglutamylates in antifolate action in cells. J. Biol. Chem. 264 29 (1989) 17016-17023
147. Selhub J., Dhar G.J., and Rosenberg I.H. Gastrointestinal absorption of antifolates. Int. Encyl. Pharmacol. Ther. 118 (1986), Pergamon, Oxford/NewYork 147-156
148. Selhub J., and Rosenberg I.H. Demonstration of high-affinity folate binding activity associated with the brush border membranes of rat kidney. Proc. Natl. Acad. Sci. USA 75 7 (1978) 3090-3093
149. Selhub J., and Rosenberg I.H. Folate transport in isolated brush border membrane vesicles from rat intestine. J. Biol. Chem. 256 9 (1981) 4489-4493
150. Seller M.J., and Nevin N.C. Periconceptional vitamin supplementation and the prevention of neural tube defects in south-east England and Northern Ireland. J. Med. Genet. 21 5 (1984) 325-330
151. Shane B. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam. Horm. 45 (1989) 263-335
152. Shayeghi M., Latunde-Dada G.O., Oakhill J.S., Laftah A.H., Takeuchi K., Halliday N., Khan Y., Warley A., McCann F.E., Hider R.C., Frazer D.M., Anderson G.J., et al. Identification of an intestinal heme transporter. Cell 122 5 (2005) 789-801
153. Shen F., Ross J.F., Wang X., and Ratnam M. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 33 5 (1994) 1209-1215
154. Shen F., Wu M., Ross J.F., Miller D., and Ratnam M. Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: Protein characterization and cell type specificity. Biochemistry 34 16 (1995) 5660-5665
155. Sierra E.E., Brigle K.E., Spinella M.J., and Goldman I.D. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH. Biochem. Pharmacol. 53 2 (1997) 223-231
156. Sirotnak F.M. Obligate genetic expression in tumor cells of a fetal membrane property mediating "folate". transport: Biological
157. Sirotnak F.M. Determinants of resistance to antifolates: Biochemical phenotypes, their frequency of occurrence and circumvention. NCI Monogr. 1987 Number 5 (1987) 27-35
158. Sirotnak F.M., and Tolner B. Carrier-mediated membrane transport of folates in mammalian cells. Annu. Rev. Nutr. 19 (1999) 91-122
159. Smit J.W., Huisman M.T., van Tellingen O., Wiltshire H.R., and Schinkel A.H. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J. Clin. Invest. 104 10 (1999) 1441-1447
160. Smithells R.W., Nevin N.C., Seller M.J., Sheppard S., Harris R., Read A.P., Fielding D.W., Walker S., Schorah C.J., and Wild J. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1 8332 (1983) 1027-1031
161. Smithells R.W., Sheppard S., and Schorah C.J. Vitamin dificiencies and neural tube defects. Arch. Dis. Child 51 12 (1976) 944-950
162. Smithells R.W., Sheppard S., Schorah C.J., Seller M.J., Nevin N.C., Harris R., Read A.P., and Fielding D.W. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch. Dis. Child 56 12 (1981) 911-918
163. Sparreboom A., van Asperen J., Mayer U., Schinkel A.H., Smit J.W., Meijer D.K., Borst P., Nooijen W.J., Beijnen J.H., and van Tellingen O. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. USA 94 5 (1997) 2031-2035
164. Spector R., and Johanson C. Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy. Pharm. Res. 23 11 (2006) 2515-2524
165. Spiegelstein O., Eudy J.D., and Finnell R.H. Identification of two putative novel folate receptor genes in humans and mouse. Gene 258 1-2 (2000) 117-125
166. Stanger O. Physiology of folic acid in health and disease. Curr. Drug Metab. 3 2 (2002) 211-223
167. Stark M., Rothem L., Jansen G., Scheffer G.L., Goldman I.D., and Assaraf Y.G. Antifolate resistance associated with loss of MRP1 expression and function in Chinese hamster ovary cells with markedly impaired export of folate and cholate. Mol. Pharmacol. 64 2 (2003) 220-227
168. Starkebaum G., and Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77 4 (1986) 1370-1376
169. Subramanian V.S., Chatterjee N., and Said H.M. Folate uptake in the human intestine: Promoter activity and effect of folate deficiency. J. Cell. Physiol. 196 2 (2003) 403-408
170. Sun X.L., and Antony A.C. Evidence that a specific interaction between an 18-base cis-element in the 5'-untranslated region of human folate receptor-alpha mRNA and a 46-kDa cytosolic trans-factor is critical for translation. J. Biol. Chem. 271 41 (1996) 25539-25547
171. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., and Gottesman M.M. Targeting multidrug resistance in cancer. Nat. Rev. Drug. Discov. 5 3 (2006) 219-234
172. Tammur J., Prades C., Arnould I., Rzhetsky A., Hutchinson A., Adachi M., Schuetz J.D., Swoboda K.J., Ptacek L.J., Rosier M., Dean M., and Allikmets R. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene 273 1 (2001) 89-96
173. Tannock I.F., and Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49 16 (1989) 4373-4384
174. Trent J.M., Buick R.N., Olson S., Horns Jr. R.C., and Schimke R.T. Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. J. Clin. Oncol. 2 1 (1984) 8-15
175. Ubbink J.B., Vermaak W.J., van der Merwe A., and Becker P.J. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am. J. Clin. Nutr. 57 1 (1993) 47-53
176. van Herwaarden A.E., Jonker J.W., Wagenaar E., Brinkhuis R.F., Schellens J.H., Beijnen J.H., and Schinkel A.H. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res. 63 19 (2003) 6447-6452
177. van Herwaarden A.E., Wagenaar E., Merino G., Jonker J.W., Rosing H., Beijnen J.H., and Schinkel A.H. Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol. Cell Biol. 27 4 (2007) 1247-1253
178. Vergel R.G., Sanchez L.R., Heredero B.L., Rodriguez P.L., and Martinez A.J. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat. Diagn. 10 3 (1990) 149-152
179. Volk E.L., and Schneider E. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res. 63 17 (2003) 5538-5543
180. Walling J. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates. Invest. New Drugs 24 1 (2006) 37-77
181. Wang X., Shen F., Freisheim J.H., Gentry L.E., and Ratnam M. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem. Pharmacol. 44 9 (1992) 1898-1901
182. Wang Y., Zhao R., and Goldman I.D. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier. Clin. Cancer Res. 10 18 Pt 1 (2004) 6256-6264
183. Weitman S.D., Weinberg A.G., Coney L.R., Zurawski V.R., Jennings D.S., and Kamen B.A. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res. 52 23 (1992) 6708-6711
184. Wielinga P., Hooijberg J.H., Gunnarsdottir S., Kathmann I., Reid G., Zelcer N., van der Born K., de Haas M., van der Heijden I., Kaspers G., Wijnholds J., Jansen G., et al. The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res. 65 10 (2005) 4425-4430
185. Wijnholds J., deLange E.C., Scheffer G.L., van den Berg D.J., Mol C.A., van der Valk M., Schinkel A.H., Scheper R.J., Breimer D.D., and Borst P. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Invest. 105 3 (2000) 279-285
186. Williams F.M., and Flintoff W.F. Structural organization of the human reduced folate carrier gene: Evidence for 5′ heterogeneity in lymphoblast mRNA. Somat. Cell Mol. Genet. 24 3 (1998) 143-156
187. Xiao X., Tang Y.S., Mackins J.Y., Sun X.L., Jayaram H.N., Hansen D.K., and Antony A.C. Isolation and characterization of a folate receptor mRNA-binding trans-factor from human placenta. Evidence favoring identity with heterogeneous nuclear ribonucleoprotein E1. J. Biol. Chem. 276 44 (2001) 41510-41517
188. Young L., Leonhard K., Tatsuta T., Trowsdale J., and Langer T. Role of the ABC transporter Mdl1 in peptide export from mitochondria. Science 291 5511 (2001) 2135-2138
189. Zeng H., Bain L.J., Belinsky M.G., and Kruh G.D. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Res. 59 23 (1999) 5964-5967
190. Zeng H., Chen Z.S., Belinsky M.G., Rea P.A., and Kruh G.D. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: Effect of polyglutamylation on MTX transport. Cancer Res. 61 19 (2001) 7225-7232
191. Zhang L., Wong S.C., and Matherly L.H. Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons. Biochem. J. 332 Pt 3 (1998) 773-780
192. Zhao R., Gao F., and Goldman I.D. Reduced folate carrier transports thiamine monophosphate: An alternative route for thiamine delivery into mammalian cells. Am. J. Physiol. Cell Physiol. 282 6 (2002) C1512-C1517
193. Zhao R., Min S.H., Qiu A., Sakaris A., Goldberg G.L., Sandoval C., Malatack J.J., Rosenblatt D.S., and Goldman I.D. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood 110 (2007) 1147-1152
194. Zhao R., Russell R.G., Wang Y., Liu L., Gao F., Kneitz B., Edelmann W., and Goldman I.D. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J. Biol. Chem. 276 13 (2001) 10224-11028
195. Zhu H., Wlodarczyk B.J., Scott M., Yu W., Merriweather M., Gelineau-van Waes J., Schwartz R.J., and Finnell R.H. Cardiovascular abnormalities in Folr1 knockout mice and folate rescue. Birth Defects Res. A Clin. Mol. Teratol. 79 4 (2007) 257-268
196. Zhu W.Y., Alliegro M.A., and Melera P.W. The rate of folate receptor alpha (FR alpha) synthesis in folate depleted CHL cells is regulated by a translational mechanism sensitive to media folate levels, while stable overexpression of its mRNA is mediated by gene amplification and an increase in transcript half-life. J. Cell. Biochem. 81 2 (2001) 205-219
197. Zhu W.Y., Bunni M., Priest D.G., DiCapua J.L., Dressler J.M., Chen Z., and Melera P.W. Severe folate restriction results in depletion of and alteration in the composition of the intracellular folate pool, moderate sensitization to methotrexate and trimetrexate, upregulation of endogenous DHFR activity, and overexpression of metallothionein II and folate receptor alpha that, upon folate repletion, confer drug resistance to CHL cells. J. Exp. Ther. Oncol. 2 5 (2002) 264-277